GRI BIO, Inc. Annual Operating Income (Loss) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
GRI BIO, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
  • GRI BIO, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.13M, a 12.7% increase year-over-year.
  • GRI BIO, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$8.31M, a 3.29% increase year-over-year.
  • GRI BIO, Inc. annual Operating Income (Loss) for 2023 was -$11.4M, a 409% decline from 2022.
  • GRI BIO, Inc. annual Operating Income (Loss) for 2022 was -$2.24M, a 75.8% increase from 2021.
  • GRI BIO, Inc. annual Operating Income (Loss) for 2021 was -$9.26M, a 93.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$11.4M -$9.15M -409% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$2.24M +$7.02M +75.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$9.26M -$4.47M -93.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-24
2020 -$4.79M Jan 1, 2020 Dec 31, 2020 10-K 2022-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.